anti cd98 Search Results


93
Miltenyi Biotec human
Human, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd98/CD98+Antibody%2C+anti-human%2C+REAfinity/pmc07219270-63-4-5
Average 93 stars, based on 1 article reviews
human - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
Bio-Rad mouse anti cd98
Mouse Anti Cd98, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd98/Rat+anti+Mouse+CD98/pmc04157101-573-40-44
Average 93 stars, based on 1 article reviews
mouse anti cd98 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
fluidigm cd98
Cd98, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd98/Anti-CD98+(Polyclonal)-173Yb/pmc09664350-86-14-15
Average 93 stars, based on 1 article reviews
cd98 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

91
Bio-Rad anti human cd98 light chain
Anti Human Cd98 Light Chain, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd98/Rabbit+anti+Human+CD98+Light+Chain+(N-Terminal)/pmc07602091-165-23-31
Average 91 stars, based on 1 article reviews
anti human cd98 light chain - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier

93
Bio-Rad human cd98
Figure 4. <t>CD98</t> immunostaining under hypoxia: Hypoxia was induced in the MDA-MB-231 cells. (A) After the hypoxia induction and galectin3 uptake, CD98 immunostaining was performed. The scale bar represents 20 μm. (B) Quantification of fluorescence intensity of CD98. (C) Quantification of fluorescence intensity of galectin3. Histobars represent the meanSD of normalized fluorescence intensity of 30 cells. Asterisks denote significant difference from the control, with *p0.05, **p0.01, ***p0.001, ****p0.0001 and ns represents non-significant difference from control.
Human Cd98, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd98/Mouse+anti+Human+CD98/pm37677117-54-4-9
Average 93 stars, based on 1 article reviews
human cd98 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
fluidigm 3159022b cd39 a1 fluidigm gd
Figure 4. <t>CD98</t> immunostaining under hypoxia: Hypoxia was induced in the MDA-MB-231 cells. (A) After the hypoxia induction and galectin3 uptake, CD98 immunostaining was performed. The scale bar represents 20 μm. (B) Quantification of fluorescence intensity of CD98. (C) Quantification of fluorescence intensity of galectin3. Histobars represent the meanSD of normalized fluorescence intensity of 30 cells. Asterisks denote significant difference from the control, with *p0.05, **p0.01, ***p0.001, ****p0.0001 and ns represents non-significant difference from control.
3159022b Cd39 A1 Fluidigm Gd, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd98/Anti-Human+CD98+(UM7F8)-159Tb/ppr0653532-314-112-115
Average 93 stars, based on 1 article reviews
3159022b cd39 a1 fluidigm gd - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

91
Alomone Labs rabbit polyclonal anti lat1 slc7a5
Basal expression of <t>SLC7A5/SLC3A2</t> in the erythroid lineage (A) The panel represents the flow cytometry analysis showing the different splenic cell populations in basal conditions based on the surface expression of CD71 and Ter119 in control mice. SLC3A2 expression is also represented by a color code: yellow-orange representing the strongest expression and dark green-blue the weakest or absence of expression. (B) Histograms showing SLC3A2 expression in the different splenic CD71 HI /Ter119 NEG/LOW , CD71 HI /Ter119 HI , CD71 NEG /Ter119 HI and CD71 NEG/LOW /Ter119 NEG cell populations in control (in blue) and ErGFPcre Slc7a5 LoxP / LoxP mice (in green). The IgG control (in gray) is included. A representative experiment out of 23 is shown.
Rabbit Polyclonal Anti Lat1 Slc7a5, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd98/Anti-LAT1+(SLC7A5)+Antibody/pmc09792907-15-0-5
Average 91 stars, based on 1 article reviews
rabbit polyclonal anti lat1 slc7a5 - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier

92
Boster Bio rabbit
Basal expression of <t>SLC7A5/SLC3A2</t> in the erythroid lineage (A) The panel represents the flow cytometry analysis showing the different splenic cell populations in basal conditions based on the surface expression of CD71 and Ter119 in control mice. SLC3A2 expression is also represented by a color code: yellow-orange representing the strongest expression and dark green-blue the weakest or absence of expression. (B) Histograms showing SLC3A2 expression in the different splenic CD71 HI /Ter119 NEG/LOW , CD71 HI /Ter119 HI , CD71 NEG /Ter119 HI and CD71 NEG/LOW /Ter119 NEG cell populations in control (in blue) and ErGFPcre Slc7a5 LoxP / LoxP mice (in green). The IgG control (in gray) is included. A representative experiment out of 23 is shown.
Rabbit, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd98/Anti-SLC7A5+Antibody/pmc10915989-83-4-7
Average 92 stars, based on 1 article reviews
rabbit - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier

92
Boster Bio anti nox1 antibody
(A) Ultra-structure of hepatocytes near cysts at different stages of infection with PSCs (0, 1, 3, and 6 months); mitochondria are indicated by white arrows,PSC are indicated by black arrows( n = 3 rats/group, scale bars represent 2 μm and 1 μm). ( B ) Fe 2+ , ( C ) GSH, ( D ( a , b )) ROS, ( E ) MDA, ( F ) SOD, and ( G ) LDH of hepatocytes near cysts at different stages of infection with PSCs. ( H ( a , b )) Western blotting of protein expression levels of TFRC, GPX4, FTH1, <t>NOX1,</t> SLC3A2, and SLC7A11 in ferroptosis signaling pathway in rat liver tissue at different stages of infection with PSCs ( n = 3 rats/group)); * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 (Student t test).
Anti Nox1 Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd98/Anti-Hu+CD98+Purified+SLC7A5+Monoclonal+Antibody/pmc11898441-85-54-56
Average 92 stars, based on 1 article reviews
anti nox1 antibody - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier

93
Boster Bio slc3a2 ab a01794 1 bosterbio
(A) Ultra-structure of hepatocytes near cysts at different stages of infection with PSCs (0, 1, 3, and 6 months); mitochondria are indicated by white arrows,PSC are indicated by black arrows( n = 3 rats/group, scale bars represent 2 μm and 1 μm). ( B ) Fe 2+ , ( C ) GSH, ( D ( a , b )) ROS, ( E ) MDA, ( F ) SOD, and ( G ) LDH of hepatocytes near cysts at different stages of infection with PSCs. ( H ( a , b )) Western blotting of protein expression levels of TFRC, GPX4, FTH1, <t>NOX1,</t> SLC3A2, and SLC7A11 in ferroptosis signaling pathway in rat liver tissue at different stages of infection with PSCs ( n = 3 rats/group)); * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 (Student t test).
Slc3a2 Ab A01794 1 Bosterbio, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd98/Anti-SLC3A2+Antibody/pmc06499991__13046_2019_1177_MOESM1_ESM-1-87-90
Average 93 stars, based on 1 article reviews
slc3a2 ab a01794 1 bosterbio - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

90
Absolute Biotech human anti-cd98 (20 μg/ml for 5 × 10 4 cells)
Sample plating layout To aid in the differentiation of control reactions from sample reactions, designate a row within a plate to controls (top row), followed by samples. Cells within the control wells will not be used to screen biological samples. The IgG Positive control will receive both the <t>anti-CD98</t> antibody, as well as the staining cocktail. Single color controls, in concert with the unstained control will provide preliminary guidance as to where to draw positive-event gates. The placements of these gates are later refined by the boundaries set by the fluorescence-minus-one controls. We separated healthy human control samples from biological human samples of interest. These healthy human controls can further refine the lower limits of positive-event gates, as it is hypothesized that healthy human controls lack or have minimal circulating autoantibodies.
Human Anti Cd98 (20 μg/Ml For 5 × 10 4 Cells), supplied by Absolute Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd98/human+anti+cd98+igg/pmc08567435-2-0-11
Average 90 stars, based on 1 article reviews
human anti-cd98 (20 μg/ml for 5 × 10 4 cells) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
MBL International rabbit anti-mouse cd98-fitc (4f2hc)
Sample plating layout To aid in the differentiation of control reactions from sample reactions, designate a row within a plate to controls (top row), followed by samples. Cells within the control wells will not be used to screen biological samples. The IgG Positive control will receive both the <t>anti-CD98</t> antibody, as well as the staining cocktail. Single color controls, in concert with the unstained control will provide preliminary guidance as to where to draw positive-event gates. The placements of these gates are later refined by the boundaries set by the fluorescence-minus-one controls. We separated healthy human control samples from biological human samples of interest. These healthy human controls can further refine the lower limits of positive-event gates, as it is hypothesized that healthy human controls lack or have minimal circulating autoantibodies.
Rabbit Anti Mouse Cd98 Fitc (4f2hc), supplied by MBL International, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd98/rabbit+anti+mouse+cd98+fitc++4f2hc+/pmc02805057-44-38-43
Average 90 stars, based on 1 article reviews
rabbit anti-mouse cd98-fitc (4f2hc) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Figure 4. CD98 immunostaining under hypoxia: Hypoxia was induced in the MDA-MB-231 cells. (A) After the hypoxia induction and galectin3 uptake, CD98 immunostaining was performed. The scale bar represents 20 μm. (B) Quantification of fluorescence intensity of CD98. (C) Quantification of fluorescence intensity of galectin3. Histobars represent the meanSD of normalized fluorescence intensity of 30 cells. Asterisks denote significant difference from the control, with *p0.05, **p0.01, ***p0.001, ****p0.0001 and ns represents non-significant difference from control.

Journal: Chembiochem : a European journal of chemical biology

Article Title: Hypoxia Modulates Cellular Endocytic Pathways and Organelles with Enhanced Cell Migration and 3D Cell Invasion.

doi: 10.1002/cbic.202300506

Figure Lengend Snippet: Figure 4. CD98 immunostaining under hypoxia: Hypoxia was induced in the MDA-MB-231 cells. (A) After the hypoxia induction and galectin3 uptake, CD98 immunostaining was performed. The scale bar represents 20 μm. (B) Quantification of fluorescence intensity of CD98. (C) Quantification of fluorescence intensity of galectin3. Histobars represent the meanSD of normalized fluorescence intensity of 30 cells. Asterisks denote significant difference from the control, with *p0.05, **p0.01, ***p0.001, ****p0.0001 and ns represents non-significant difference from control.

Article Snippet: Mouse monoclonal antibodies to human CD98 were purchased from BioRad.

Techniques: Immunostaining, Fluorescence, Control

Basal expression of SLC7A5/SLC3A2 in the erythroid lineage (A) The panel represents the flow cytometry analysis showing the different splenic cell populations in basal conditions based on the surface expression of CD71 and Ter119 in control mice. SLC3A2 expression is also represented by a color code: yellow-orange representing the strongest expression and dark green-blue the weakest or absence of expression. (B) Histograms showing SLC3A2 expression in the different splenic CD71 HI /Ter119 NEG/LOW , CD71 HI /Ter119 HI , CD71 NEG /Ter119 HI and CD71 NEG/LOW /Ter119 NEG cell populations in control (in blue) and ErGFPcre Slc7a5 LoxP / LoxP mice (in green). The IgG control (in gray) is included. A representative experiment out of 23 is shown.

Journal: iScience

Article Title: Erythroid SLC7A5/SLC3A2 amino acid carrier controls red blood cell size and maturation

doi: 10.1016/j.isci.2022.105739

Figure Lengend Snippet: Basal expression of SLC7A5/SLC3A2 in the erythroid lineage (A) The panel represents the flow cytometry analysis showing the different splenic cell populations in basal conditions based on the surface expression of CD71 and Ter119 in control mice. SLC3A2 expression is also represented by a color code: yellow-orange representing the strongest expression and dark green-blue the weakest or absence of expression. (B) Histograms showing SLC3A2 expression in the different splenic CD71 HI /Ter119 NEG/LOW , CD71 HI /Ter119 HI , CD71 NEG /Ter119 HI and CD71 NEG/LOW /Ter119 NEG cell populations in control (in blue) and ErGFPcre Slc7a5 LoxP / LoxP mice (in green). The IgG control (in gray) is included. A representative experiment out of 23 is shown.

Article Snippet: Rabbit polyclonal Anti-LAT1 (SLC7A5) , Alomone Labs , Cat# ANT-105, RRID: AB_2756724.

Techniques: Expressing, Flow Cytometry, Analysis, Control, FACS

SLC7A5/SLC3A2 expression in splenic erythroblasts during erythropoietic stress (A) Representative flow cytometry analysis showing the different splenic cell populations in control and PHZ-treated mice based on the surface expression of CD71 and Ter119: CD71 HI /Ter119 NEG/LOW , CD71 HI /Ter119 HI , and CD71 NEG/LOW /Ter119 NEG . (B) Relative Slc7a5 mRNA expression in the spleen of control (n = 8) and ErGFPcre Slc7a5 LoxP / LoxP (n = 3) mice in baseline conditions as well as control (n = 6) and ErGFPcre Slc7a5 LoxP / LoxP (n = 5) upon PHZ treatment. Data are shown as mean ± SEM. Statistical analysis was performed using a two-tailed Student’s t test with Welch’s correction to compare the groups as indicated in the figure (∗p < 0.05). (C) Histograms showing SLC3A2 expression in each of the populations indicated in untreated control mice (in blue) and control mice treated with PHZ (in red) are shown in left panels. In the right panels, the same histograms of the left panels are shown, but overlaying the histogram of SLC3A2 expression of ErGFPcre Slc7a5 LoxP/LoxP (in green) mice treated with PHZ. The IgG-APC control is presented in gray. For A and C a representative experiment out of 9 is shown. (D) Representative flow cytometry analysis of DRAQ5 expression versus forward scatter (FSC) of the splenic CD71 HI /Ter119 HI erythroid population of PHZ-treated control mice. Two CD71 HI /Ter119 HI populations differing in DRAQ5 signal can be distinguished, DRAQ5 HI and DRAQ5 LOW . The dashed line represents unlabeled cells. (E) Representative histograms of SLC3A2 expression in CD71 HI /Ter119 HI /DRAQ5 HI and CD71 HI /Ter119 HI /DRAQ5 LOW populations in control mice treated with PHZ (in red) and ErGFPcre Slc7a5 LoxP/LoxP (in green) mice treated with PHZ are shown. The negative signal of the IgG-PyC control is shown in gray. For D and E a representative experiment out of 7 is shown.

Journal: iScience

Article Title: Erythroid SLC7A5/SLC3A2 amino acid carrier controls red blood cell size and maturation

doi: 10.1016/j.isci.2022.105739

Figure Lengend Snippet: SLC7A5/SLC3A2 expression in splenic erythroblasts during erythropoietic stress (A) Representative flow cytometry analysis showing the different splenic cell populations in control and PHZ-treated mice based on the surface expression of CD71 and Ter119: CD71 HI /Ter119 NEG/LOW , CD71 HI /Ter119 HI , and CD71 NEG/LOW /Ter119 NEG . (B) Relative Slc7a5 mRNA expression in the spleen of control (n = 8) and ErGFPcre Slc7a5 LoxP / LoxP (n = 3) mice in baseline conditions as well as control (n = 6) and ErGFPcre Slc7a5 LoxP / LoxP (n = 5) upon PHZ treatment. Data are shown as mean ± SEM. Statistical analysis was performed using a two-tailed Student’s t test with Welch’s correction to compare the groups as indicated in the figure (∗p < 0.05). (C) Histograms showing SLC3A2 expression in each of the populations indicated in untreated control mice (in blue) and control mice treated with PHZ (in red) are shown in left panels. In the right panels, the same histograms of the left panels are shown, but overlaying the histogram of SLC3A2 expression of ErGFPcre Slc7a5 LoxP/LoxP (in green) mice treated with PHZ. The IgG-APC control is presented in gray. For A and C a representative experiment out of 9 is shown. (D) Representative flow cytometry analysis of DRAQ5 expression versus forward scatter (FSC) of the splenic CD71 HI /Ter119 HI erythroid population of PHZ-treated control mice. Two CD71 HI /Ter119 HI populations differing in DRAQ5 signal can be distinguished, DRAQ5 HI and DRAQ5 LOW . The dashed line represents unlabeled cells. (E) Representative histograms of SLC3A2 expression in CD71 HI /Ter119 HI /DRAQ5 HI and CD71 HI /Ter119 HI /DRAQ5 LOW populations in control mice treated with PHZ (in red) and ErGFPcre Slc7a5 LoxP/LoxP (in green) mice treated with PHZ are shown. The negative signal of the IgG-PyC control is shown in gray. For D and E a representative experiment out of 7 is shown.

Article Snippet: Rabbit polyclonal Anti-LAT1 (SLC7A5) , Alomone Labs , Cat# ANT-105, RRID: AB_2756724.

Techniques: Expressing, Flow Cytometry, Analysis, Control, Two Tailed Test, FACS

SLC7A5/SLC3A2 expression in circulating CD71 HI /Ter119 HI reticulocytes under anemic conditions and in response to rhEPO (A) Representative flow cytometry analysis showing circulating CD71 HI /Ter119 HI reticulocytes in PHZ-treated and control mice, as well as in mice subjected to phlebotomy. For PHZ a representative experiment out of 20 is shown. For phlebotomy, a representative experiment out of 8 is shown. (B) Representative histograms of SLC3A2 expression in circulating CD71 HI /Ter119 HI reticulocytes of untreated control mice (in blue), mice treated with PHZ or mice subjected to phlebotomy (in red), as well as ErGFPcre Slc7a5 LoxP/LoxP mice treated with PHZ or subjected to phlebotomy (in green). The IgG-APC control is represented in gray. Quantification of the mean fluorescence intensity (MFI) of SLC3A2 on circulating CD71 HI /Ter119 HI reticulocytes from control untreated mice (n = 33), control mice treated with PHZ (n = 20), ErGFPcre Slc7a5 LoxP/+ untreated mice (n = 11), ErGFPcre Slc7a5 LoxP/+ mice treated with PHZ (n = 10), ErGFPcre Slc7a5 LoxP/LoxP untreated mice (n = 16) and ErGFPcre Slc7a5 LoxP/LoxP mice treated with PHZ (n = 14). Quantification of the mean fluorescence intensity (MFI) of SLC3A2 on circulating CD71 HI /Ter119 HI reticulocytes from control mice (n = 8), control mice subjected to phlebotomy (n = 8), ErGFPcre Slc7a5 LoxP/+ untreated mice (n = 4), ErGFPcre Slc7a5 LoxP/+ mice subjected to phlebotomy (n = 4), ErGFPcre Slc7a5 LoxP / LoxP untreated mice (n = 3) and ErGFPcre Slc7a5 LoxP/LoxP mice subjected to phlebotomy (n = 3). (C) Western blot analyses of SLC7A5 relative to β-actin protein levels in circulating erythroid cells of control and ErGFPcre Slc7a5 LoxP/LoxP PHZ-treated mice. (D) L-phenylalanine uptake in isolated CD71 HI /Ter119 HI circulating reticulocytes from PHZ-treated control or ErGFPcre Slc7a5 LoxP/LoxP mice (n = 5). (E) Representative flow cytometry analysis of CD71 expression versus GYPA in healthy and anemic subjects (left panels). Histograms of SLC3A2 expression in circulating CD71 HI /GYPA HI and CD71 NEG /GYPA HI populations of control (blue) and anemic (red) subjects (right panels). A representative experiment out of 3 anemic subjects and 3 control subjects is shown. (F) Representative histograms of SLC3A2 expression in circulating CD71 HI /Ter119 HI reticulocytes of untreated control mice (blue) or mice treated with rhEPO (200U) (red). The IgG-APC control is represented in gray. Quantification of the mean fluorescence intensity (MFI) of SLC3A2 on circulating CD71 HI /Ter119 HI reticulocytes from untreated (n = 5) or rhEPO-treated control mice (n = 5), as well as from untreated (n = 3) or rhEPO-treated ErGFPcre Slc7a5 LoxP/LoxP mice (n = 5). Data are shown as mean ± SEM. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test when comparing more than two groups or two-tailed Student’s t test with Welch’s correction when comparing two groups (∗∗p < 0.01; ∗∗∗p < 0.005).

Journal: iScience

Article Title: Erythroid SLC7A5/SLC3A2 amino acid carrier controls red blood cell size and maturation

doi: 10.1016/j.isci.2022.105739

Figure Lengend Snippet: SLC7A5/SLC3A2 expression in circulating CD71 HI /Ter119 HI reticulocytes under anemic conditions and in response to rhEPO (A) Representative flow cytometry analysis showing circulating CD71 HI /Ter119 HI reticulocytes in PHZ-treated and control mice, as well as in mice subjected to phlebotomy. For PHZ a representative experiment out of 20 is shown. For phlebotomy, a representative experiment out of 8 is shown. (B) Representative histograms of SLC3A2 expression in circulating CD71 HI /Ter119 HI reticulocytes of untreated control mice (in blue), mice treated with PHZ or mice subjected to phlebotomy (in red), as well as ErGFPcre Slc7a5 LoxP/LoxP mice treated with PHZ or subjected to phlebotomy (in green). The IgG-APC control is represented in gray. Quantification of the mean fluorescence intensity (MFI) of SLC3A2 on circulating CD71 HI /Ter119 HI reticulocytes from control untreated mice (n = 33), control mice treated with PHZ (n = 20), ErGFPcre Slc7a5 LoxP/+ untreated mice (n = 11), ErGFPcre Slc7a5 LoxP/+ mice treated with PHZ (n = 10), ErGFPcre Slc7a5 LoxP/LoxP untreated mice (n = 16) and ErGFPcre Slc7a5 LoxP/LoxP mice treated with PHZ (n = 14). Quantification of the mean fluorescence intensity (MFI) of SLC3A2 on circulating CD71 HI /Ter119 HI reticulocytes from control mice (n = 8), control mice subjected to phlebotomy (n = 8), ErGFPcre Slc7a5 LoxP/+ untreated mice (n = 4), ErGFPcre Slc7a5 LoxP/+ mice subjected to phlebotomy (n = 4), ErGFPcre Slc7a5 LoxP / LoxP untreated mice (n = 3) and ErGFPcre Slc7a5 LoxP/LoxP mice subjected to phlebotomy (n = 3). (C) Western blot analyses of SLC7A5 relative to β-actin protein levels in circulating erythroid cells of control and ErGFPcre Slc7a5 LoxP/LoxP PHZ-treated mice. (D) L-phenylalanine uptake in isolated CD71 HI /Ter119 HI circulating reticulocytes from PHZ-treated control or ErGFPcre Slc7a5 LoxP/LoxP mice (n = 5). (E) Representative flow cytometry analysis of CD71 expression versus GYPA in healthy and anemic subjects (left panels). Histograms of SLC3A2 expression in circulating CD71 HI /GYPA HI and CD71 NEG /GYPA HI populations of control (blue) and anemic (red) subjects (right panels). A representative experiment out of 3 anemic subjects and 3 control subjects is shown. (F) Representative histograms of SLC3A2 expression in circulating CD71 HI /Ter119 HI reticulocytes of untreated control mice (blue) or mice treated with rhEPO (200U) (red). The IgG-APC control is represented in gray. Quantification of the mean fluorescence intensity (MFI) of SLC3A2 on circulating CD71 HI /Ter119 HI reticulocytes from untreated (n = 5) or rhEPO-treated control mice (n = 5), as well as from untreated (n = 3) or rhEPO-treated ErGFPcre Slc7a5 LoxP/LoxP mice (n = 5). Data are shown as mean ± SEM. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test when comparing more than two groups or two-tailed Student’s t test with Welch’s correction when comparing two groups (∗∗p < 0.01; ∗∗∗p < 0.005).

Article Snippet: Rabbit polyclonal Anti-LAT1 (SLC7A5) , Alomone Labs , Cat# ANT-105, RRID: AB_2756724.

Techniques: Expressing, Flow Cytometry, Analysis, Control, Fluorescence, Western Blot, Isolation, Two Tailed Test, FACS

Mice lacking SLC7A5 in the erythroid lineage develop hypererythropoietinemia and smaller circulating RBCs (A) Serum EPO protein (pg/mL) in control mice (n = 18), ErGFPcre Slc7a5 LoxP/+ mice (n = 4), and ErGFPcre Slc7a5 LoxP/LoxP mice (n = 13) under baseline conditions; in control mice (n = 18), ErGFPcre Slc7a5 LoxP/+ mice (n = 9) and ErGFPcre Slc7a5 LoxP/LoxP mice (n = 16) after PHZ treatment; and in phlebotomized control mice (n = 6), ErGFPcre Slc7a5 LoxP/+ mice (n = 4) and ErGFPcre Slc7a5 LoxP/LoxP mice (n = 6). (B) Total number of circulating RBCs in control mice (n = 28), ErGFPcre Slc7a5 LoxP/+ mice (n = 13), and ErGFPcre Slc7a5 LoxP/LoxP mice (n = 18) under basal conditions or in control mice (n = 13), ErGFPcre Slc7a5 LoxP/+ mice (n = 9), and ErGFPcre Slc7a5 LoxP/LoxP mice (n = 13) after PHZ treatment. (C) Mean corpuscular volume (MCV, μm 3 ) of circulating RBCs in control mice (n = 28), ErGFPcre Slc7a5 LoxP/+ mice (n = 13), and ErGFPcre Slc7a5 LoxP/LoxP mice (n = 18) under basal conditions, and in control mice (n = 11), ErGFPcre Slc7a5 LoxP/+ mice (n = 7), and ErGFPcre Slc7a5 LoxP/LoxP mice (n = 12) after PHZ treatment. (D) Representative images of life imaging morphology cytometry (left) and 3D-cell rendering images (right) of RBCs of ErGFPcre Slc7a5 LoxP/LoxP and control mice. The RBC populations normally distributed their areas around a central average smaller for the ErGFPcre Slc7a5 LoxP / LoxP specimens than for control mice (central panels). Graph panels show the diameter (μm), area (μm 2 ), and elongation (%) of RBCs in control, and ErGFPcre Slc7a5 LoxP/LoxP mice. Data are shown as mean ± SEM. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test when comparing three groups or two-tailed Student’s t test with Welch’s correction when comparing two groups (∗p < 0.05; ∗∗∗p < 0.005).

Journal: iScience

Article Title: Erythroid SLC7A5/SLC3A2 amino acid carrier controls red blood cell size and maturation

doi: 10.1016/j.isci.2022.105739

Figure Lengend Snippet: Mice lacking SLC7A5 in the erythroid lineage develop hypererythropoietinemia and smaller circulating RBCs (A) Serum EPO protein (pg/mL) in control mice (n = 18), ErGFPcre Slc7a5 LoxP/+ mice (n = 4), and ErGFPcre Slc7a5 LoxP/LoxP mice (n = 13) under baseline conditions; in control mice (n = 18), ErGFPcre Slc7a5 LoxP/+ mice (n = 9) and ErGFPcre Slc7a5 LoxP/LoxP mice (n = 16) after PHZ treatment; and in phlebotomized control mice (n = 6), ErGFPcre Slc7a5 LoxP/+ mice (n = 4) and ErGFPcre Slc7a5 LoxP/LoxP mice (n = 6). (B) Total number of circulating RBCs in control mice (n = 28), ErGFPcre Slc7a5 LoxP/+ mice (n = 13), and ErGFPcre Slc7a5 LoxP/LoxP mice (n = 18) under basal conditions or in control mice (n = 13), ErGFPcre Slc7a5 LoxP/+ mice (n = 9), and ErGFPcre Slc7a5 LoxP/LoxP mice (n = 13) after PHZ treatment. (C) Mean corpuscular volume (MCV, μm 3 ) of circulating RBCs in control mice (n = 28), ErGFPcre Slc7a5 LoxP/+ mice (n = 13), and ErGFPcre Slc7a5 LoxP/LoxP mice (n = 18) under basal conditions, and in control mice (n = 11), ErGFPcre Slc7a5 LoxP/+ mice (n = 7), and ErGFPcre Slc7a5 LoxP/LoxP mice (n = 12) after PHZ treatment. (D) Representative images of life imaging morphology cytometry (left) and 3D-cell rendering images (right) of RBCs of ErGFPcre Slc7a5 LoxP/LoxP and control mice. The RBC populations normally distributed their areas around a central average smaller for the ErGFPcre Slc7a5 LoxP / LoxP specimens than for control mice (central panels). Graph panels show the diameter (μm), area (μm 2 ), and elongation (%) of RBCs in control, and ErGFPcre Slc7a5 LoxP/LoxP mice. Data are shown as mean ± SEM. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test when comparing three groups or two-tailed Student’s t test with Welch’s correction when comparing two groups (∗p < 0.05; ∗∗∗p < 0.005).

Article Snippet: Rabbit polyclonal Anti-LAT1 (SLC7A5) , Alomone Labs , Cat# ANT-105, RRID: AB_2756724.

Techniques: Control, Imaging, Morphology, Cytometry, Analysis, Two Tailed Test

Erythroid-SLC7A5 deficient mice have red blood cells with lower hemoglobin content (A) Mean corpuscular hemoglobin (MCH, pg) of circulating RBCs in control mice (n = 28), ErGFPcre Slc7a5 LoxP/+ mice (n = 13), and ErGFPcre Slc7a5 LoxP/LoxP mice (n = 18) under basal conditions. (B) Representative peripheral blood stainings with May-Grünwald-Giemsa of ErGFPcre Slc7a5 LoxP/LoxP (right) and control (left) mice. (C) Representative flow cytometry histograms comparing the phospho-rpS6 Ser235/6 signal in CD71 HI /Ter119 HI splenic erythroblasts of control and temsirolimus-treated mice (left panel). Representative flow cytometry histogram comparing the phospho-rpS6 Ser235/6 signal in CD71 HI /Ter119 HI splenic erythroblasts in control, and ErGFPcre Slc7a5 LoxP/LoxP mice (right panel). Quantification of phospho-rpS6 Ser235/6 signal from control (n = 6) and temsirolimus-treated mice (n = 5) (left panel). Quantification of phospho-rpS6 Ser235/6 signal from control (n = 9), ErGFPcre Slc7a5 LoxP/+ mice (n = 8), and ErGFPcre Slc7a5 LoxP/LoxP mice (n = 7) (right panel). The dashed line represents unlabeled permeabilized cells. Data are shown as mean ± SEM. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test when comparing three groups or two-tailed Student’s t test with Welch’s correction when comparing two groups (∗p < 0.05; ∗∗∗p < 0.005).

Journal: iScience

Article Title: Erythroid SLC7A5/SLC3A2 amino acid carrier controls red blood cell size and maturation

doi: 10.1016/j.isci.2022.105739

Figure Lengend Snippet: Erythroid-SLC7A5 deficient mice have red blood cells with lower hemoglobin content (A) Mean corpuscular hemoglobin (MCH, pg) of circulating RBCs in control mice (n = 28), ErGFPcre Slc7a5 LoxP/+ mice (n = 13), and ErGFPcre Slc7a5 LoxP/LoxP mice (n = 18) under basal conditions. (B) Representative peripheral blood stainings with May-Grünwald-Giemsa of ErGFPcre Slc7a5 LoxP/LoxP (right) and control (left) mice. (C) Representative flow cytometry histograms comparing the phospho-rpS6 Ser235/6 signal in CD71 HI /Ter119 HI splenic erythroblasts of control and temsirolimus-treated mice (left panel). Representative flow cytometry histogram comparing the phospho-rpS6 Ser235/6 signal in CD71 HI /Ter119 HI splenic erythroblasts in control, and ErGFPcre Slc7a5 LoxP/LoxP mice (right panel). Quantification of phospho-rpS6 Ser235/6 signal from control (n = 6) and temsirolimus-treated mice (n = 5) (left panel). Quantification of phospho-rpS6 Ser235/6 signal from control (n = 9), ErGFPcre Slc7a5 LoxP/+ mice (n = 8), and ErGFPcre Slc7a5 LoxP/LoxP mice (n = 7) (right panel). The dashed line represents unlabeled permeabilized cells. Data are shown as mean ± SEM. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test when comparing three groups or two-tailed Student’s t test with Welch’s correction when comparing two groups (∗p < 0.05; ∗∗∗p < 0.005).

Article Snippet: Rabbit polyclonal Anti-LAT1 (SLC7A5) , Alomone Labs , Cat# ANT-105, RRID: AB_2756724.

Techniques: Control, Flow Cytometry, Analysis, Two Tailed Test, FACS

Loss of SLC7A5 in the erythroid lineage increases the transition between circulating reticulocytes and mature erythrocytes (A) Flow cytometry histogram comparing the CD71 expressed by circulating Ter119 positive cells in a control, and ErGFPcre Slc7a5 LoxP/LoxP mice after PHZ treatment. Quantification of the proportion of CD71 HI /Ter119 HI , CD71 INT /Ter119 HI , and CD71 NEG /Ter119 HI in control (n = 35), ErGFPcre Slc7a5 LoxP/+ mice (n = 19), and ErGFPcre Slc7a5 LoxP/LoxP mice (n = 28) after PHZ treatment. The range of CD71 expression considered for the quantification of CD71 HI /Ter119 HI , CD71 INT /Ter119 HI , and CD71 NEG /Ter119 HI RBCs is indicated. (B) Flow cytometry histogram comparing the TMRM signal in circulating CD71 HI /Ter119 HI reticulocytes of control, and ErGFPcre Slc7a5 LoxP/LoxP mice after PHZ treatment. Quantification of TMRM signal from control (n = 7), ErGFPcre Slc7a5 LoxP/+ mice (n = 6), and ErGFPcre Slc7a5 LoxP/LoxP mice (n = 7) after PHZ treatment. The dashed line represents unlabeled cells. (C) Maximal mitochondrial oxygen consumption rate (OCR) in circulating cells of PHZ-treated mice (n = 14) and PHZ-treated ErGFPcre Slc7a5 LoxP/LoxP mice (n = 15). Data are shown as mean ± SEM. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test when comparing three groups or two-tailed Student’s t test with Welch’s correction when comparing two groups (∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.005).

Journal: iScience

Article Title: Erythroid SLC7A5/SLC3A2 amino acid carrier controls red blood cell size and maturation

doi: 10.1016/j.isci.2022.105739

Figure Lengend Snippet: Loss of SLC7A5 in the erythroid lineage increases the transition between circulating reticulocytes and mature erythrocytes (A) Flow cytometry histogram comparing the CD71 expressed by circulating Ter119 positive cells in a control, and ErGFPcre Slc7a5 LoxP/LoxP mice after PHZ treatment. Quantification of the proportion of CD71 HI /Ter119 HI , CD71 INT /Ter119 HI , and CD71 NEG /Ter119 HI in control (n = 35), ErGFPcre Slc7a5 LoxP/+ mice (n = 19), and ErGFPcre Slc7a5 LoxP/LoxP mice (n = 28) after PHZ treatment. The range of CD71 expression considered for the quantification of CD71 HI /Ter119 HI , CD71 INT /Ter119 HI , and CD71 NEG /Ter119 HI RBCs is indicated. (B) Flow cytometry histogram comparing the TMRM signal in circulating CD71 HI /Ter119 HI reticulocytes of control, and ErGFPcre Slc7a5 LoxP/LoxP mice after PHZ treatment. Quantification of TMRM signal from control (n = 7), ErGFPcre Slc7a5 LoxP/+ mice (n = 6), and ErGFPcre Slc7a5 LoxP/LoxP mice (n = 7) after PHZ treatment. The dashed line represents unlabeled cells. (C) Maximal mitochondrial oxygen consumption rate (OCR) in circulating cells of PHZ-treated mice (n = 14) and PHZ-treated ErGFPcre Slc7a5 LoxP/LoxP mice (n = 15). Data are shown as mean ± SEM. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test when comparing three groups or two-tailed Student’s t test with Welch’s correction when comparing two groups (∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.005).

Article Snippet: Rabbit polyclonal Anti-LAT1 (SLC7A5) , Alomone Labs , Cat# ANT-105, RRID: AB_2756724.

Techniques: Flow Cytometry, Control, Expressing, Analysis, Two Tailed Test, FACS

Journal: iScience

Article Title: Erythroid SLC7A5/SLC3A2 amino acid carrier controls red blood cell size and maturation

doi: 10.1016/j.isci.2022.105739

Figure Lengend Snippet:

Article Snippet: Rabbit polyclonal Anti-LAT1 (SLC7A5) , Alomone Labs , Cat# ANT-105, RRID: AB_2756724.

Techniques: Cell-Signaling, Immunology, Control, Recombinant, Enzyme-linked Immunosorbent Assay, Knock-In, Amplification, Software, Analysis

(A) Ultra-structure of hepatocytes near cysts at different stages of infection with PSCs (0, 1, 3, and 6 months); mitochondria are indicated by white arrows,PSC are indicated by black arrows( n = 3 rats/group, scale bars represent 2 μm and 1 μm). ( B ) Fe 2+ , ( C ) GSH, ( D ( a , b )) ROS, ( E ) MDA, ( F ) SOD, and ( G ) LDH of hepatocytes near cysts at different stages of infection with PSCs. ( H ( a , b )) Western blotting of protein expression levels of TFRC, GPX4, FTH1, NOX1, SLC3A2, and SLC7A11 in ferroptosis signaling pathway in rat liver tissue at different stages of infection with PSCs ( n = 3 rats/group)); * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 (Student t test).

Journal: Cells

Article Title: Echinococcus granulosus -Induced Liver Damage Through Ferroptosis in Rat Model

doi: 10.3390/cells14050328

Figure Lengend Snippet: (A) Ultra-structure of hepatocytes near cysts at different stages of infection with PSCs (0, 1, 3, and 6 months); mitochondria are indicated by white arrows,PSC are indicated by black arrows( n = 3 rats/group, scale bars represent 2 μm and 1 μm). ( B ) Fe 2+ , ( C ) GSH, ( D ( a , b )) ROS, ( E ) MDA, ( F ) SOD, and ( G ) LDH of hepatocytes near cysts at different stages of infection with PSCs. ( H ( a , b )) Western blotting of protein expression levels of TFRC, GPX4, FTH1, NOX1, SLC3A2, and SLC7A11 in ferroptosis signaling pathway in rat liver tissue at different stages of infection with PSCs ( n = 3 rats/group)); * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 (Student t test).

Article Snippet: The antibodies used in this study were as follows: TFRC (Boster, 1: 500, Rabbit, BA0462-2, Wuhan, China); Caspase-3 (Boster, 1:500, Rabbit, BA3257, Wuhan, China); GSDMD (Proteintech Group, 1:800, Rabbit, 20770-1-AP, Wuhan, China); LC3I/II (Abcam, 1:1000, Rabbit, ab192890, Shanghai, China); Anti-GPX4 Antibody (Boster, 1:400, Rabbit, BM5231,Wuhan, China); Anti-FTH1 Antibody (Boster, China, 1:400, Rabbit, BM4487,Wuhan, China); Anti-NOX1 Antibody (Boster, China, 1:400, Rabbit, BA3720,Wuhan, China); Anti-CD98 Antibody (SLC3A2, Boster, China, 1:400, Rabbit, A01794-1,Wuhan,China); Anti-xCT Antibody (SLC7A11,Abcam,1:400, Rabbit, A01794-1, Shanghai, China); β-actin (Sino Biological, 1:1000, Mouse, 100166-MM10, Beijing, China).

Techniques: Infection, Western Blot, Expressing

( A ) Fe 2+ in normal BRL cells, PSCs and BRL co-cultured cells, and PSCs +Ferrostatin-1 and BRL co-cultured cells. ( B ) GSH, ( C ) GSSH, ( D ) GSH/GSSH, ( E ) SOD, ( F ) LDH, and ( G ) MDA concentration detection ( n = 6 rats/group). ( H ( a , b )) Western-blotting detection of expression levels of cell ferroptosis signaling pathway proteins in each group, such as TFRC, GPX4, FTH1, NOX1, SLC3A2, andSLC7A11 ( n = 3 rats/group); * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 (Student t test).

Journal: Cells

Article Title: Echinococcus granulosus -Induced Liver Damage Through Ferroptosis in Rat Model

doi: 10.3390/cells14050328

Figure Lengend Snippet: ( A ) Fe 2+ in normal BRL cells, PSCs and BRL co-cultured cells, and PSCs +Ferrostatin-1 and BRL co-cultured cells. ( B ) GSH, ( C ) GSSH, ( D ) GSH/GSSH, ( E ) SOD, ( F ) LDH, and ( G ) MDA concentration detection ( n = 6 rats/group). ( H ( a , b )) Western-blotting detection of expression levels of cell ferroptosis signaling pathway proteins in each group, such as TFRC, GPX4, FTH1, NOX1, SLC3A2, andSLC7A11 ( n = 3 rats/group); * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 (Student t test).

Article Snippet: The antibodies used in this study were as follows: TFRC (Boster, 1: 500, Rabbit, BA0462-2, Wuhan, China); Caspase-3 (Boster, 1:500, Rabbit, BA3257, Wuhan, China); GSDMD (Proteintech Group, 1:800, Rabbit, 20770-1-AP, Wuhan, China); LC3I/II (Abcam, 1:1000, Rabbit, ab192890, Shanghai, China); Anti-GPX4 Antibody (Boster, 1:400, Rabbit, BM5231,Wuhan, China); Anti-FTH1 Antibody (Boster, China, 1:400, Rabbit, BM4487,Wuhan, China); Anti-NOX1 Antibody (Boster, China, 1:400, Rabbit, BA3720,Wuhan, China); Anti-CD98 Antibody (SLC3A2, Boster, China, 1:400, Rabbit, A01794-1,Wuhan,China); Anti-xCT Antibody (SLC7A11,Abcam,1:400, Rabbit, A01794-1, Shanghai, China); β-actin (Sino Biological, 1:1000, Mouse, 100166-MM10, Beijing, China).

Techniques: Cell Culture, Concentration Assay, Western Blot, Expressing

Sample plating layout To aid in the differentiation of control reactions from sample reactions, designate a row within a plate to controls (top row), followed by samples. Cells within the control wells will not be used to screen biological samples. The IgG Positive control will receive both the anti-CD98 antibody, as well as the staining cocktail. Single color controls, in concert with the unstained control will provide preliminary guidance as to where to draw positive-event gates. The placements of these gates are later refined by the boundaries set by the fluorescence-minus-one controls. We separated healthy human control samples from biological human samples of interest. These healthy human controls can further refine the lower limits of positive-event gates, as it is hypothesized that healthy human controls lack or have minimal circulating autoantibodies.

Journal: STAR Protocols

Article Title: A flow-cytometry-based protocol using diverse cell types for detecting autoantibodies from human plasma and serum samples

doi: 10.1016/j.xpro.2021.100924

Figure Lengend Snippet: Sample plating layout To aid in the differentiation of control reactions from sample reactions, designate a row within a plate to controls (top row), followed by samples. Cells within the control wells will not be used to screen biological samples. The IgG Positive control will receive both the anti-CD98 antibody, as well as the staining cocktail. Single color controls, in concert with the unstained control will provide preliminary guidance as to where to draw positive-event gates. The placements of these gates are later refined by the boundaries set by the fluorescence-minus-one controls. We separated healthy human control samples from biological human samples of interest. These healthy human controls can further refine the lower limits of positive-event gates, as it is hypothesized that healthy human controls lack or have minimal circulating autoantibodies.

Article Snippet: Human anti-CD98 (20 μg/mL for 5 × 10 4 cells) , Absolute Antibody , Ab00361–10.0.

Techniques: Positive Control, Staining, Fluorescence

Journal: STAR Protocols

Article Title: A flow-cytometry-based protocol using diverse cell types for detecting autoantibodies from human plasma and serum samples

doi: 10.1016/j.xpro.2021.100924

Figure Lengend Snippet:

Article Snippet: Human anti-CD98 (20 μg/mL for 5 × 10 4 cells) , Absolute Antibody , Ab00361–10.0.

Techniques: Recombinant, Electron Microscopy, Flow Cytometry